30 January 2019
As a precursor to the forthcoming Isle of Man consultation on the Regulation of Hemp & Medicinal Cannabis, Manx Biomed Association invited Saul Kaye from iCAN and Chris Bolton from Theracann to present at the annual Manx Biomed Conference.
Saul and Chris spoke about their first-hand experience of setting up regulatory systems around the world including within Israel, Canada, USA, Australia and New Zealand, and the lessons to be learned from those experiences in order to do it better next time.
The topic attracted much attention and several interviews took place during the conference, relavent liks have been included below:
Mark Gledhill from the Department for Enterprise talks about this year’s Manx Biomed Conference
Saul Kaye from ICAN and Chris Bolton from Theracann - Part One of an interview recorded at this year’s Manx Biomed Conference
Saul Kaye from ICAN and Chris Bolton from Theracann - Part two of the interview recorded at this year’s Manx Biomed conference
Jeff Ditchfield, CEO of Bud Buddies, has devoted his life to researching the medicinal benefits of cannabis
House of Keys Statement: Cannabis medicinal regulations Isle of Man - Will changes to the Schedule 1 status of cannabis based products for medicinal use set out in the Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018 extend to the Isle of Man?